| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |